| NDC Code | 25021-784-10 |
|---|
| Package Description | 1 VIAL in 1 CARTON (25021-784-10) > 5 mL in 1 VIAL |
|---|
| Product NDC | 25021-784 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Fosaprepitant |
|---|
| Non-Proprietary Name | Fosaprepitant Dimeglumine |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20191215 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA204845 |
|---|
| Manufacturer | Sagent Pharmaceuticals |
|---|
| Substance Name | FOSAPREPITANT DIMEGLUMINE |
|---|
| Strength | 150 |
|---|
| Strength Unit | mg/5mL |
|---|
| Pharmacy Classes | Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA] |
|---|